Continental Controls has informed that the Board of Directors at its Meeting held on Wednesday 15th July, 2026 considered and after due deliberation approved the following: 1. Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 50 Crores, to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently), subject to receipt of statutory / regulatory approvals in accordance with the amended SEBI (Issuer of Capital and Disclosure Requirements) Amendment Regulations, 2025 (the ‘SEBI ICDR Regulations’) and other applicable regulations and subject to necessary approvals as may be required. For the purposes of giving effect to the Rights Issue, the detailed terms to the Rights Issue including but not limited to issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course by the Board / Rights Issue Committee, in accordance with applicable laws, subject to receipt of necessary approvals, as may be required. Requisite details for the aforesaid in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (‘SEBI Master Circular’), is enclosed as Annexure - A. 2. The Board also approved the constitution of the Rights Issue Committee, for the purposes of issue, offer and allotment of Equity Shares, and other matters in connection with or incidental to the Rights Issue. The details of the Rights Issue Committee are provided in Annexure B. 3. Standalone Unaudited Financial Results of the company for the quarter ended June 30, 2026. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, it has enclosed the statement showing the Standalone Financial Results for the quarter ended June 30 2026 along with the Limited Review Report. This declaration is given in compliance of Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. 4. To acquire from Onelife Capital Advisors (OCAL), commercial rights to two specific software applications ‘Ready Shopping’ (targeted at shopping businesses) and ‘Ready Pharmacy’ (targeted at pharmacy businesses) • Fixed License Fee amounting to Rs 53,99,603/- including all associated operational concepts, commercial workflows, methodologies, and proprietary business know-how as more particularly described in the software licensing, joint intellectual property, and business support agreement 5. Approval to pay to OCAL a Strategic Collaboration Participation Fee/ Royalty of 0.50% of Gross Revenue (as defined in the software licensing, joint intellectual property, and business support agreement), payable quarterly, on a continuing basis, in consideration of ongoing strategic guidance, business development support and Touch Ecosystem participation provided by OCAL. 6. Appointment of Purva Sharegistry (India) (SEBI Registration No. INR000001112) as the Registrar to the Issue. 7. Appointment of ICICI Bank as the Banker to the Issue/Escrow Collection Bank/Refund Bank. 8. Opening Escrow Account with ICICI Bank. 9. Appointment of Acuite Ratings & Research as the Monitoring Agency for the proposed Rights Issue. 10. Appointment of Aadhar Agarwal & Co., Chartered Accountants, as Internal Auditor of the Company for Financial Year 2026-27 Annexure C. 11. Noting of Resignation of Jyoti Darade from the office of Company Secretary and Compliance Officer of the Company. Annexure D. 12. Appointment of Anushree Tekriwal as the Company Secretary and Key Managerial Personnel of the Company, with effect from 15th July 2026. Annexure E. 13. in terms of the omnibus approval already granted by the Audit Committee and the shareholders for related party transactions with Dealmoney Commodities (‘DCPL’) up to ?10 crore for FY 2026-27, accorded for the Company to take on leave and license approximately 1,500 sq. ft. of premises at 1st Floor, Plot No. A-356 & 357, Road No. 26, Wagle Estate, Thane (West), from DCPL, on payment of a refundable, interest-free security deposit of ?1,50,00,000 at a monthly rental of Rs 5000/-. 14. Noting of Resignation of Khusbu Agrawal, DIN 09847254 as Independent Director of the Company. Annexure F. 15. Appointment of Dr. Ranu Jain (DIN: 11012104) as Non-Executive Independent Additional Director of the company with effect from 15th July 2026, Annexure G. 16. Appointment of Santosh Bhattacharjee DIN: 02447452 as Non-Executive Independent Additional Director of the company with effect from 15th July 2026. Annexure H. The meeting of the Board of Directors of the Company commenced at 11:00 am and concluded at 23:30 pm.
The above information is a part of company’s filings submitted to BSE.
